PMID: 9659518Jul 11, 1998Paper

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity

Oral Oncology
S T Sonis

Abstract

Mucositis induced by antineoplastic drugs is an important, dose-limiting and costly side effect of cancer therapy. The ulcerative lesions which result are frequent systemic portals of entry for microorganisms which inhabit the mouth and consequently are often sources of systemic infection in the myelosuppressed patient. A number of clinical observations and the inconsistency of responses to a broad range of treatment modalities suggests a physiological complexity to mucositis which has not previously been comprehensively considered. We now propose a hypothesis as to the mechanism by which mucositis develops and resolves, which is based on four phases: an initial inflammatory/vascular phase; an epithelial phase; an ulcerative/bacteriological phase; and a healing phase. The role of cytokines as initiators and ampliers of the process is discussed, as is the potential influence of genetic factors in establishing risk and modifying the course of stomatotoxicity.

Associated Clinical Trials

References

Jul 1, 1979·Oral Surgery, Oral Medicine, and Oral Pathology·P B Lockhart, S T Sonis
Dec 1, 1975·Archives of Oral Biology·G Shklar, S T Sonis
Dec 11, 1992·Oral Surgery, Oral Medicine, and Oral Pathology·S T SonisM Nicolson
May 1, 1992·The American Journal of Medicine·R G WadleighM H Cohen
Jun 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L S EltingB H Keefe
Apr 1, 1990·Oral Surgery, Oral Medicine, and Oral Pathology·S T SonisD Florine
Jul 1, 1988·Oral Surgery, Oral Medicine, and Oral Pathology·D A KolbinsonE L Truelove
Dec 1, 1981·The Journal of Dermatologic Surgery and Oncology·P B Lockhart, S T Sonis
Jul 1, 1995·European Journal of Cancer. Part B, Oral Oncology·S T Sonis, K A Costello
Mar 1, 1994·Current Opinion in Oncology·J L Ferrara
Jul 1, 1995·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·C J VerdiT Burkhead
Oct 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K H ChiK Y Chen
Jul 1, 1994·European Journal of Cancer. Part B, Oral Oncology·S CascinuG Catalano
Jan 5, 1995·The New England Journal of Medicine·A G Papavassiliou
Sep 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·C J Verdi
Oct 1, 1995·Journal of Pain and Symptom Management·B A MuellerT H Wiser
Jan 1, 1996·Immunologic Research·W Krenger, J L Ferrara
Nov 1, 1996·European Journal of Cancer. Part B, Oral Oncology·C TardieuJ C Franquin
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin

❮ Previous
Next ❯

Citations

Mar 8, 2008·Cancer Chemotherapy and Pharmacology·Pedro M G SoaresMarcellus H L P Souza
Mar 21, 2008·Cancer Chemotherapy and Pharmacology·Richard M LoganDorothy M K Keefe
Aug 20, 2009·Cancer Chemotherapy and Pharmacology·K L TooleyR N Butler
Dec 15, 2010·Cancer Chemotherapy and Pharmacology·Pedro M G SoaresMarcellus H L P Souza
Nov 19, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Gerry J BarkerJudith E Raber-Durlacher
Apr 11, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rachel J Gibson, Dorothy M K Keefe
Mar 28, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rajesh V LallaDorothy Keefe
Nov 30, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Claire BarberJulie Hewett
Mar 30, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Anncarin SvanbergKerstin Ohrn
Jan 17, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Arsinoi XanthinakiEfstratios Patsouris
May 15, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sonja LüerChristoph Aebi
Mar 11, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jin Won KimYung-Jue Bang
Apr 16, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Haruhiko KashiwazakiNobuo Inoue
Oct 12, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nobue SaitoToshimi Sairenchi
Dec 23, 2011·Inflammopharmacology·Wai-Man TangShun-Wan Chan
May 5, 2005·International Journal of Oral and Maxillofacial Surgery·T IkebeK Shirasuna
Apr 12, 2000·International Journal of Radiation Oncology, Biology, Physics·A Trotti
Dec 1, 1999·Infectious Disease Clinics of North America·J B Epstein, A W Chow
Oct 29, 2000·International Journal of Antimicrobial Agents·J Herrstedt
Jul 4, 2001·Oral Oncology·I von BültzingslöwenT Kardos
Oct 9, 2001·Oral Oncology·J B Epstein, P Stevenson-Moore
Jan 3, 2003·Oral Oncology·Andrei Barasch, Douglas E Peterson
Nov 27, 2007·Nature Clinical Practice. Oncology·Francesco BertoldoVincenzo Lo Cascio
Apr 26, 2002·British Journal of Haematology·Nicole M A BlijlevensBen E de Pauw
Jul 26, 2002·Cell Proliferation·S T SonisJ D Haley
Mar 20, 2002·Cancer Practice·M J DoddG Shiba
Dec 17, 2004·The New England Journal of Medicine·Ricardo SpielbergerChristos Emmanouilides
Apr 2, 2002·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Ernesta ParisiThomas P Sollecito
Aug 24, 2002·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Joel B EpsteinJonathan A Ship
Mar 11, 2011·Critical Reviews in Food Science and Nutrition·Luca D PrisciandaroGordon S Howarth
Nov 23, 2013·Photomedicine and Laser Surgery·Jurema Freire Lisboa de CastroFrancisco de Paula Ramos Pedrosa
May 6, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E SchmidtW E Berdel
Jul 23, 1999·Current Opinion in Oncology·D E Peterson
Mar 12, 2004·Anti-cancer Drugs·Jill P SmithIan S Zagon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.